9th May 2024 7:00 am |
RNS |
Arecor and Medtronic Diabetes collaboration |
3rd May 2024 4:44 pm |
RNS |
Publication of Full Year Financial Results delayed |
29th Apr 2024 7:00 am |
RNS |
Notice of results |
23rd Apr 2024 7:00 am |
RNS |
BOARD CHANGE |
12th Mar 2024 8:58 am |
RNS |
Arecor and TRx Biosciences research collaboration |
12th Mar 2024 7:00 am |
RNS |
Arecor and TRx Biosciences research collaboration |
29th Feb 2024 7:00 am |
RNS |
Arecor announces launch of Ogluo® in Netherlands |
1st Feb 2024 7:00 am |
RNS |
Year End Trading Update |
23rd Jan 2024 4:58 pm |
RNS |
Arecor announces update on INBRX-101 |
18th Jan 2024 7:00 am |
RNS |
Arecor granted key European patent |
8th Jan 2024 7:00 am |
RNS |
Expansion of specialty hospital collaboration |
3rd Jan 2024 7:00 am |
RNS |
Appointment of SVP for Tetris Pharma Ltd |
4th Dec 2023 7:00 am |
RNS |
Agreement with global medical products company |
29th Nov 2023 7:00 am |
RNS |
Arecor Continues Collaboration with Lilly |
17th Nov 2023 7:00 am |
RNS |
Product with Arestat technology launched in Europe |
2nd Nov 2023 7:00 am |
RNS |
Inhibrx milestone triggers payment to Arecor |
1st Nov 2023 3:31 pm |
RNS |
Exercise of rollover options & Total Voting Rights |
2nd Oct 2023 7:00 am |
RNS |
Progress of Phase I clinical study of AT278 |
15th Sep 2023 7:00 am |
RNS |
Arecor on Investor Meet Company Platform |
14th Sep 2023 7:00 am |
RNS |
Interim Results for six months ended 30 June 2023 |
7th Sep 2023 7:00 am |
RNS |
Arecor: positive Hikma FDA pre-IND meeting |
4th Sep 2023 7:00 am |
RNS |
TETRIS PHARMA ANNOUNCES AGREEMENT WITH GOODLIFE |
17th Aug 2023 7:00 am |
RNS |
Collaboration With Top 10 Global Pharma |
10th Aug 2023 7:00 am |
RNS |
Notice of Interim Results |
20th Jul 2023 7:00 am |
RNS |
Arecor Business Update |
5th Jul 2023 7:00 am |
RNS |
Additional Agreement with Leading Biopharma |
27th Jun 2023 7:00 am |
RNS |
Arecor granted key patents in Europe and China |
26th Jun 2023 7:00 am |
RNS |
Arecor presents positive data for AT247 at ADA |
9th Jun 2023 3:35 pm |
RNS |
Exercise of rollover options & Total Voting Rights |
9th Jun 2023 12:43 pm |
RNS |
Result of AGM |
9th Jun 2023 7:00 am |
RNS |
AGM Statement |
24th May 2023 7:00 am |
RNS |
Director/PDMR Shareholding |
15th May 2023 7:00 am |
RNS |
TETRIS PHARMA LAUNCHES OGLUO® IN DENMARK & NORWAY |
4th May 2023 4:00 pm |
RNS |
ARECOR 2022 ANNUAL REPORT AND NOTICE OF AGM |
26th Apr 2023 7:00 am |
RNS |
Arecor Granted Key U.S Patent |
21st Apr 2023 7:00 am |
RNS |
Arecor on Investor Meet Company Platform |
20th Apr 2023 7:00 am |
RNS |
Unaudited Preliminary Results for 2022 |
5th Apr 2023 7:00 am |
RNS |
Arecor Appoints Chief Business Officer |
22nd Mar 2023 7:00 am |
RNS |
FIRST PATIENT DOSED IN AT278 CLINICAL TRIAL |
13th Mar 2023 4:35 pm |
RNS |
Price Monitoring Extension |